Abstract
The NF-κB transcription factor pathway is a crucial regulator of inflammation and immune responses. Additionally, aberrant NF-κB signaling has been identified in many types of cancer. Downstream of key oncogenic pathways, such as RAS, BCR-ABL, and Her2, NF-κB regulates transcription of target genes that promote cell survival and proliferation, inhibit apoptosis, and mediate invasion and metastasis. The cancer stem cell model posits that a subset of tumor cells (cancer stem cells) drive tumor initiation, exhibit resistance to treatment, and promote recurrence and metastasis. This review examines the evidence for a role for NF-κB signaling in cancer stem cell biology.
Original language | English (US) |
---|---|
Journal | Cells |
Volume | 5 |
Issue number | 2 |
DOIs | |
State | Published - Apr 6 2016 |
Externally published | Yes |
Keywords
- Cancer
- Cancer stem cells
- NF-κB
- Self-renewal
- Tumor-initiating cells
ASJC Scopus subject areas
- General Medicine